In this project, we will focus on cohesively developing advanced AI technologies to revolutionise imaging-based diagnosis of disease and extend our work towards commercial applications and clinical deployment. Specifically, we will first target three disease area cohorts where AI can greatly assist medical professionals: cancer (breast, brain, melanoma), lung diseases (e.g., COVID-19), and neurological conditions.